United States
Germany
Japan
United Kingdom
China
Anti-DLL4 Reference Antibody (enoticumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Antibodies
Anti-DLL4 Reference Antibody (navicixizumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
Anti-DLL4 Reference Antibody (Smart Targeting patent anti-DLL4)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-DLL4 Reference Antibody (demcizumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Mouse |
